National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Polaprezinc
Synonyms

Zinc, (beta-alanyl-kappaN-L-histidinato(2-)-kappaN,kappaO)-

Carnosine Zinc Complex

Polaprezinc

Zinc L-carnosine

POLAPREZINC

Aprozinate

Z 103

Definitions

An orally bioavailable chelate composed of zinc and L-carnosine, with potential gastroprotective, anti-oxidant, anti-ulcer and anti-inflammatory activities. Upon administration, polaprezinc increases the expression of various anti-oxidant enzymes, such as superoxide dismutase 1 (SOD-1), SOD-2, heme oxygenase-1 (HO-1), glutathione S-transferase (GST), glutathione peroxidase (GSH-px), peroxidredoxin-1 (PRDX1; PRXI) and PRXD5 (PRXV) in the gastric mucosa, which protect cells against reactive oxygen species (ROS). In addition, this agent inhibits the activity of the transcription factor nuclear factor-kappaB (NF-kappaB) and reduces the expression of several pro-inflammatory cytokines, such as interleukin (IL) 1beta, IL-6, IL-8, and tumor necrosis factor alpha (TNF-a). Polaprezinc also increases the expression of various growth factors, such as platelet-derived growth factor-B (PDGF-B), vascular endothelial growth factor (VEGF), and nerve growth factor (NGF), and various heat shock proteins (HSPs), including HSP90, HSP70, HSP60, HSP47, HSP27, and HSP10. This protects against damages to, and accelerates healing of the gastric mucosa.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C118371

CAS_Registry

107667-60-7

code

C118371

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

An orally bioavailable chelate composed of zinc and L-carnosine, with potential gastroprotective, anti-oxidant, anti-ulcer and anti-inflammatory activities. Upon administration, polaprezinc increases the expression of various anti-oxidant enzymes, such as superoxide dismutase 1 (SOD-1), SOD-2, heme oxygenase-1 (HO-1), glutathione S-transferase (GST), glutathione peroxidase (GSH-px), peroxidredoxin-1 (PRDX1; PRXI) and PRXD5 (PRXV) in the gastric mucosa, which protect cells against reactive oxygen species (ROS). In addition, this agent inhibits the activity of the transcription factor nuclear factor-kappaB (NF-kappaB) and reduces the expression of several pro-inflammatory cytokines, such as interleukin (IL) 1beta, IL-6, IL-8, and tumor necrosis factor alpha (TNF-a). Polaprezinc also increases the expression of various growth factors, such as platelet-derived growth factor-B (PDGF-B), vascular endothelial growth factor (VEGF), and nerve growth factor (NGF), and various heat shock proteins (HSPs), including HSP90, HSP70, HSP60, HSP47, HSP27, and HSP10. This protects against damages to, and accelerates healing of the gastric mucosa.

FDA_UNII_Code

0WA1B15A1Z

FULL_SYN

Zinc, (beta-alanyl-kappaN-L-histidinato(2-)-kappaN,kappaO)-

Carnosine Zinc Complex

Polaprezinc

Zinc L-carnosine

POLAPREZINC

Aprozinate

Z 103

label

Polaprezinc

NCI_Drug_Dictionary_ID

764859

PDQ_Closed_Trial_Search_ID

764859

PDQ_Open_Trial_Search_ID

764859

Preferred_Name

Polaprezinc

prefixIRI

Thesaurus:C118371

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0286382

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29701

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26170

Delete Subject Author Type Created
No notes to display